# Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D

> **NCT02163213** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 15 (actual)

## Conditions studied

- Diarrhea-predominant Irritable Bowel Syndrome

## Interventions

- **OTHER:** Serum-derived bovine immunoglobulin protein isolate (SBI)

## Key facts

- **NCT ID:** NCT02163213
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-11-01
- **Final completion:** 2016-11-02
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02163213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02163213, "Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02163213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*